BioMarin Pharmaceutical Inc.
News
Cantor Fitzgerald Reiterates "Overweight" Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)
Ticker Report BioMarin Pharmaceutical (NASDAQ:BMRN - Get Free Report)s stock had its "overweight" rating reissued by stock analysts at Cantor Fitzgerald in a research note issued on Monday, Benzinga...\n more…
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by Brokerages
Ticker Report BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) has received an average recommendation of "Moderate Buy" from the twenty-three brokerages that are presently covering the firm, Marketbeat...\n more…
Arizona State Retirement System Acquires 320 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Ticker Report Arizona State Retirement System raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 0.6% in the second quarter, according to its most recent 13F filing with the...\n more…
Arizona State Retirement System Buys 320 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Zolmax Arizona State Retirement System increased its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 0.6% during the 2nd quarter, Holdings Channel.com reports. The fund owned...\n more…
Leerink Partnrs Brokers Boost Earnings Estimates for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Ticker Report BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Stock analysts at Leerink Partnrs upped their Q3 2024 earnings per share (EPS) estimates for BioMarin Pharmaceutical in a research note...\n more…
CIBC Asset Management Inc Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Zolmax CIBC Asset Management Inc grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 5.4% in the second quarter, according to the company in its most recent Form 13F...\n more…